SCHRODER INVESTMENT MANAGEMENT GROUP
Position in GILD — Gilead Sciences, Inc.
CIK 1086619
London, X0
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$215,505,842
-$5,466,265 QoQ
Shares Held
1,705,761
+7.6% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#87
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $4,791,103,609 across 11 Drug Manufacturers - General names. GILD ranks #8 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,277,161 | $1,531,865,340 | |
| 2 | JNJ |
Johnson & Johnson
|
3,563,268 | $904,963,170 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
12,226,954 | $704,517,086 | |
| 4 | ABBV |
AbbVie Inc.
|
2,280,159 | $573,779,209 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,455,664 | $315,552,823 | |
| 6 | PFE |
Pfizer Inc
|
12,896,296 | $310,542,805 | |
| 7 | AMGN |
Amgen Inc
|
613,694 | $222,230,868 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,705,761 | $215,505,842 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $215,505,842 | 1,705,761 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $220,972,107 | 1,585,507 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $210,375,007 | 1,713,989 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $226,772,556 | 2,042,996 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $231,845,798 | 2,091,150 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $241,456,878 | 2,154,903 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $211,170,841 | 2,286,141 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $167,961,196 | 2,003,354 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $130,811,960 | 1,906,602 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $116,045,579 | 1,584,240 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $133,390,172 | 1,646,589 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $113,452,412 | 1,513,910 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $103,827,083 | 1,347,179 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $128,283,813 | 1,546,147 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $148,830,503 | 1,733,611 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $110,795,361 | 1,796,002 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $112,773,393 | 1,824,517 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $55,687,109 | 936,705 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $59,980,071 | 826,058 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $60,931,130 | 872,314 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $91,202,108 | 1,324,457 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $109,576,222 | 1,695,439 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $133,980,405 | 2,299,698 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $133,003,827 | 2,104,824 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $135,720,697 | 1,763,981 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $125,611,825 | 1,680,201 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||